New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in Asia REDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 ...

Based in Hangzhou, China and listed on the Hong Kong Stock Exchange, Zylox-Tonbridge has developed and launched 36 products into the Greater China interventional markets since its founding in 2012.

HANGZHOU, China, March 21, 2022 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, hereinafter called "the Company") announced on March 15 its first fiscal-year financial report since its IPO on Hong Kong ...

HANGZHOU, China, March 7, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China ...

HANGZHOU, China, April 23, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the "Company") announced the signing of a strategic agreement with Guangdong Hicicare ...

HANGZHOU, China, Aug. 26, 2024 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK), a leading player in China's peripheral and neurovascular intervention markets, today announced ...

HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

HANGZHOU, China, Aug. 30, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZENFlow ...

1 Day 2190 -1.26% DJIA 0.55% S&P Mid Cap 400 0.73% Health Care/Life Sciences 1.41% ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.